Stay updated on Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Footer label updated from Revision: v3.2.0 to Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-27T03:49:54.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The government funding lapse notice on the ClinicalTrials.gov page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-19T22:08:09.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    No meaningful content changes were detected between the old and new screenshots; the study details, sections, and layout appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-10-29T10:05:21.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    - Added a government funding and operating-status notice and links to official sources; updated version to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    3%
    Check dated 2025-10-07T23:09:29.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Update: revision version changed from v3.0.2 to v3.1.0, a metadata/branding update with no substantive content changes.
    Difference
    0.1%
    Check dated 2025-09-30T02:30:18.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Page updated to revision v3.0.2; the previous v3.0.1 tag was removed along with the Back to Top link. No substantive changes to core content or functional data.
    Difference
    0.2%
    Check dated 2025-09-15T19:25:10.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial page.